These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 44785)

  • 21. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further comparisons between cefuroxime and cefamandole in its in vitro activity.
    Bergström S; Normark S
    Scand J Infect Dis Suppl; 1980; suppl 25():30-1. PubMed ID: 7010538
    [No Abstract]   [Full Text] [Related]  

  • 24. [The antibacterial efficacy of cefaclor against bacteria resistant to ampicillin, tetracycline and co-trimoxazole (author's transl)].
    Machka K
    Infection; 1979; 7 Suppl 6():536-9. PubMed ID: 399244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics of resistance to cephalosporins.
    Atkinson BA
    Chemioterapia; 1985 Feb; 4(1):19-23. PubMed ID: 3986942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple drug resistance in Klebsiella-Enterobacter, Proteus mirabilis and Pseudomonas aeruginosa--an analysis of all-nation computer-processed data.
    Grunt J; Krcméry V
    Zentralbl Bakteriol Orig A; 1976 Oct; 236(1):105-12. PubMed ID: 826047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.
    Kosmidis J; Hamilton-Miller JM; Gilchrist JN; Kerry DW; Brumfitt W
    Br Med J; 1973 Dec; 4(5893):653-5. PubMed ID: 4202265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cephalosporin resistance in strains of Klebsiella oxytoca isolated during antibiotic therapy.
    Then RL; Glauser MP; Angehrn P; Arisawa M
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):469-79. PubMed ID: 6609500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cephalosporins: activity and clinical use.
    Weinstein AJ
    Drugs; 1980 Aug; 20(2):137-54. PubMed ID: 6995096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole.
    Greenberg RN; Bollinger M
    Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysis if enterobacteria by cefoxitin, cefuroxime, and cephalothin.
    Goodwin CS; Hill JP
    Antimicrob Agents Chemother; 1977 Jan; 11(1):26-30. PubMed ID: 319751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
    Mirimanoff RO; Héraïef E
    Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG; Stilwell GA; Turck M
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of effectiveness of antibiotics by anaerobiosis.
    Verklin RM; Mandell GL
    J Lab Clin Med; 1977 Jan; 89(1):65-71. PubMed ID: 318675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibacterial activity of cefamandole in vitro.
    Meyers BR; Hirschman SZ
    J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.